Risk Management, Sterile Pharmaceutical Products and a Post-Brexit UK Pharma Industry

This article highlights some of the key aspects of the contamination control strategy, including how GMP requirements in ICH Q9 have been guiding manufacturers to identify and mitigate risk. Our industry expert John Johnson also discusses the effects of Brexit on pharmaceutical manufacturers.